Impairment of hepatic drug metabolism in alcoholics. 1979

A W Harman, and D B Frewin, and B G Priestly, and C B Alexander

1 The effects of chronic ethanol intake on the elimination kinetics of antipyrine were determined in nineteen male alcoholic subjects with comparison made to fourteen male volunteers. 2 Half-lives were longer and clearance values less in the alcoholic group. 3 Significant rank correlations were found between half-life and clearance when compared with various biochemical parameters of liver function measured in the plasma of the alcoholics. 4 These results show that a significant proportion of the alcoholics studied had impaired hepatic drug metabolizing capacity and that the activity of hepatic microsomal enzymes may be related to the extent of ethanol induced liver damage in these subjects.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000437 Alcoholism A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4) Alcohol Abuse,Alcoholic Intoxication, Chronic,Ethanol Abuse,Alcohol Addiction,Alcohol Dependence,Alcohol Use Disorder,Abuse, Alcohol,Abuse, Ethanol,Addiction, Alcohol,Alcohol Use Disorders,Chronic Alcoholic Intoxication,Dependence, Alcohol,Intoxication, Chronic Alcoholic,Use Disorders, Alcohol

Related Publications

A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
July 1966, Biochemical pharmacology,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
January 1982, Pharmacology & therapeutics,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
January 1970, Toxicology and applied pharmacology,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
March 1973, Science (New York, N.Y.),
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
January 1982, European journal of drug metabolism and pharmacokinetics,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
April 1982, The Indian journal of medical research,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
June 1976, Biochemical pharmacology,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
November 1974, British medical journal,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
December 1974, Life sciences,
A W Harman, and D B Frewin, and B G Priestly, and C B Alexander
March 1978, European journal of clinical pharmacology,
Copied contents to your clipboard!